Keywords: Obesity, Glucagon-like-peptide-1 receptor agonists, Empathy, Communication, Drug-safety Introduction It is common for patients to express concern about starting glucagon-like-peptide-1 receptor agonists (GLP-1RA), worrying that these medications are too new or that their long-term effects are unknown
CVD prevalence has more than doubled during the last three decades, with the burden of CVD borne disproportionately by individuals with diabetes, who experience a two- to four-fold higher risk of cardiovascular events and mortality [1,2,3]
R.MartelC.MorrisA
This test analyzes key variants in GLP1R, GIPR, FTO, and MC4R pathways, mapping 14 biological pathways and 150+ genetic insights to refine your treatment plan
Zaparcia, wzdcia, bl brzucha
When standard, unformulated glutathione is ingested, the highly acidic environment of the stomach (which has a pH of less than 1.5) and the aggressive digestive enzymes (peptidases) in the small intestine rapidly cleave the tripeptide into its three constituent amino acids